VETAFILM™, R&D SERVICES FOR
VETERINARY ORAL FILM TECHNOLOGY
VetaFilmTM research and development services and veterinary oral films provide significant
market opportunities for improved drug delivery for companion animals:
![cutomiz](/images/NewIntel/tecnology/vetafilm/dog1.jpg)
![dog2](/images/NewIntel/tecnology/vetafilm/VS3.png)
![dog2](/images/NewIntel/tecnology/vetafilm/cat_injection.jpg)
![middle banner VersaFilm](/images/NewIntel/tecnology/vetafilm/absor.png)
Absorption Routes
![cutomiz](/images/NewIntel/tecnology/vetafilm/veta_absorption_routes_1.png)
Oral drug delivery
![dog2](/images/NewIntel/tecnology/vetafilm/veta_absorption_routes_2.png)
Transmucosal drug delivery
TRANSMUCOSAL
VetaFilmTM R&D services are based on a versatile drug delivery platform technology that enables the development of oral thin films exhibiting improved product performance:
![cutomiz](/images/NewIntel/tecnology/vetafilm/VetaFilm-LINGUAL.png)
LINGUAL
![cutomiz](/images/NewIntel/tecnology/vetafilm/VetaFilm-Buccal.png)
BUCCAL
![dog2](/images/NewIntel/tecnology/vetafilm/VetaFilm-Sublingual.png)
SUBLINGUAL
![middle banner VersaFilm](/images/NewIntel/tecnology/vetafilm/banner-cat-white.jpg)
VETAFILM™ DOSAGE FORM ADVANTAGES ARE NUMEROUS
![]() | ![]() | ![]() | |
---|---|---|---|
Immediate Release | Directional Release | Controlled Release | |
Multiple Species | |||
Mucoadhesive | |||
Multiple Actives | |||
Bolus Release | |||
Reduced GI Side Effects | |||
Reduced First Pass Effect | |||
Controlled Release |